Hey, I'm all for things turning out as planned, and I realise that everyone says that there'll be three new licencing agreements. There's agreement on the number ('3'), so there must be negotiations going on. Everyone has good intentions ;)
In my experience (with biotechs and small caps in general) timelines seem to always be stretched. Therefore, I express my doubt that the most probable outcome is for all three to make it over the Dec finishing line.
Please come back and dump on me if they do - I won't mind one bit!
Ann: Broker Research Report , page-10
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.0¢ | $357.8K | 3.346M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 359383 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 1340637 | 7 |
View Market Depth
| Last trade - 15.56pm 21/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |